Effective January 1, 2026, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will require prior authorization for all bioengineered skin and soft tissue substitute codes.
This update complies with Centers for Medicare & Medicaid Services (CMS) mandates, which requires the Plan to provide a sixty (60) day notice when adding new codes to prior authorization requirements.
This new policy will apply to all Blue Medicare HMO℠, Blue Medicare PPO℠, Healthy Blue + Medicare℠ (HMO-POS D-SNP), Blue Medicare Rx℠ members, and members of any third-party Medicare plans supported by Blue Cross NC through administrative or operational services.
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.